Clinical Value of Serum sTim-3, CEA, CA15-3 for Postoperative Recurrence of Breast Cancer
Serum sTim-3 levels may assist in the staging of BC. Combined detection of sTim-3, CEA, and CA15-3 can be used to routinely monitor the progression of BC and indicate the risk of postoperative BC recurrence.
Authors
- Xueqin Zhao (ORCID: https://orcid.org/0000-0002-4214-6599)
- Ting Shen (ORCID: https://orcid.org/0000-0002-0018-0115)
- Xiumei Zhou (ORCID: https://orcid.org/0009-0001-2664-0327)
- Biao Huang (ORCID: https://orcid.org/0000-0003-1883-0670)
- Qin Yuan (ORCID: https://orcid.org/0000-0002-0269-3504)
- Haiyan Gao (ORCID: https://orcid.org/0000-0003-3545-4224)
- Jialong Wu (ORCID: https://orcid.org/0009-0002-3407-1299)
- Hongming Fang
Institutions
- Zhejiang Sci-Tech University (CN)
- University of Electronic Science and Technology of China (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/cmar.s508321
- Citations
- 2
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 2.09